Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in J Med Virol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    January 2019
  1. GOPALAN BP, D'Souza RR, Rajnala N, Arumugam K, et al
    Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug-resistance and virological failure in children.
    J Med Virol. 2019 Jan 29. doi: 10.1002/jmv.25413.
    PubMed     Text format     Abstract available


    December 2018
  2. BAVARO DF, Saracino A, Fiordelisi D, Bruno G, et al
    Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV co-infected individuals.
    J Med Virol. 2018 Dec 22. doi: 10.1002/jmv.25385.
    PubMed     Text format     Abstract available


  3. LIU Y, Margot N, Kitrinos KM, Callebaut C, et al
    Development of an HIV-1 Integrase Genotyping Assay for HIV-1 Subtype AE.
    J Med Virol. 2018 Dec 13. doi: 10.1002/jmv.25376.
    PubMed     Text format     Abstract available


  4. SINGH L, Bell TG, Yousif M, Kramvis A, et al
    Response of hepatitis B virus to anti-retroviral treatment containing lamivudine in HBsAg-positive and HBsAg-negative HIV-positive South African adults.
    J Med Virol. 2018 Dec 4. doi: 10.1002/jmv.25375.
    PubMed     Text format     Abstract available


    November 2018
  5. MALAGNINO V, Bottero J, Miailhes P, Lascoux-Combe C, et al
    Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection.
    J Med Virol. 2018 Nov 15. doi: 10.1002/jmv.25360.
    PubMed     Text format     Abstract available


    September 2018
  6. ROLDAN EQ, Properzi M, Amadasi S, Raffetti E, et al
    Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of Hepatocellular carcinoma (HCC): a single-centre study.
    J Med Virol. 2018 Sep 14. doi: 10.1002/jmv.25317.
    PubMed     Text format     Abstract available


  7. NADAN S, Taylor MB, Groome MJ, Cohen C, et al
    Epidemiology of human astroviruses among children younger than 5 years: Prospective hospital-based sentinel surveillance in South Africa, 2009-2014.
    J Med Virol. 2018 Sep 7. doi: 10.1002/jmv.25308.
    PubMed     Text format     Abstract available


  8. GUOPING D, Xiaoshan L, Musa TH, Yu J, et al
    The Nationwide Distribution and Trends of Hepatitis C Virus Genotypes in Mainland China.
    J Med Virol. 2018 Sep 7. doi: 10.1002/jmv.25311.
    PubMed     Text format     Abstract available


    August 2018
  9. GILANI US, Memoona, Rasheed A, Shahid M, et al
    The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
    J Med Virol. 2018 Aug 22. doi: 10.1002/jmv.25292.
    PubMed     Text format     Abstract available


  10. JORDIER F, Deligny ML, Barre R, Robert C, et al
    Human pegivirus (HPgV) isolates characterized by deep sequencing from HCV- and HIV-RNA positive blood donations, France.
    J Med Virol. 2018 Aug 22. doi: 10.1002/jmv.25290.
    PubMed     Text format     Abstract available


  11. KAHYESH-ESFANDIARY R, Sadigh ZA, Esghaei M, Bastani MN, et al
    Detection of HCV Genome in Peripheral Blood Mononuclear Cells of Iranian Seropositive and HCV RNA negative in Plasma of Patients with Beta-thalassemia Major: Occult HCV Infection.
    J Med Virol. 2018 Aug 9. doi: 10.1002/jmv.25279.
    PubMed     Text format     Abstract available


  12. FLORES GL, Cruz HM, Miguel JC, Potsch DV, et al
    Assessing Hepatitis B immunity using dried blood spot samples from HIV(+) individuals.
    J Med Virol. 2018 Aug 7. doi: 10.1002/jmv.25275.
    PubMed     Text format     Abstract available


    July 2018
  13. JOGEDA EL, Avi R, Pauskar M, Kallas E, et al
    Association of IFNlambda4 rs12979860 Polymorphism with the Acquisition of HCV and HIV Infections among People Who Inject Drugs.
    J Med Virol. 2018 Jul 10. doi: 10.1002/jmv.25258.
    PubMed     Text format     Abstract available


  14. SONG JE, Ahn MY, Kim WJ, Kim SW, et al
    Prevalence of CCR5 tropism among HIV-1-infected patients in South Korea.
    J Med Virol. 2018 Jul 7. doi: 10.1002/jmv.25254.
    PubMed     Text format     Abstract available


    June 2018
  15. DEGEFA B, Gebreeyesus T, Gebremedhin Z, Melkamu G, et al
    Prevalence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: A three year retrospective study.
    J Med Virol. 2018 Jun 15. doi: 10.1002/jmv.25248.
    PubMed     Text format     Abstract available


  16. KARKASHADZE E, Dvali N, Bolokadze N, Sharvadze L, et al
    Epidemiology of HIV drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia.
    J Med Virol. 2018 Jun 15. doi: 10.1002/jmv.25245.
    PubMed     Text format     Abstract available


    May 2018
  17. SMELOV V, Elfstrom KM, Eklund C, Sokolova O, et al
    Determinants of presence of human papillomaviruses in the anal canal of Russian men.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25234.
    PubMed     Text format     Abstract available


  18. TAMALET C, Tissot-Dupont H, Motte A, Tourres C, et al
    Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25228.
    PubMed     Text format     Abstract available


  19. HILDENBRAND C, Wedekind L, Li G, vonRentzell JE, et al
    Clinical evaluation of Roche COBAS((R)) AmpliPrep/COBAS((R)) TaqMan((R)) CMV Test using non-plasma samples.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25226.
    PubMed     Text format     Abstract available


  20. NICOT F, Jeanne N, Raymond S, Delfour O, et al
    Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.
    J Med Virol. 2018 May 11. doi: 10.1002/jmv.25224.
    PubMed     Text format     Abstract available


  21. DE DIEU LONGO J, Bouassa RM, Simaleko MM, Kouabosso A, et al
    Usefulness of simultaneous screening for HIV- and HCV- specific antibodies and HBsAg by capillary-based multiplex rapid diagnostic test to strengthen linkage-to-care in sub-Saharan patients attending sexually transmitted infections clinic.
    J Med Virol. 2018 May 2. doi: 10.1002/jmv.25209.
    PubMed     Text format     Abstract available


    April 2018
  22. KUAI Q, Lu X, Qiao Z, Wang R, et al
    Histone deacetylase inhibitor chidamide promotes reactivation of latent HIV by introducing histone acetylation.
    J Med Virol. 2018 Apr 28. doi: 10.1002/jmv.25207.
    PubMed     Text format     Abstract available


  23. PIRAYESHFARD L, Sharifi Z, Amini-Kafiabad S, Sadaghiani NH, et al
    Phylogenetic analysis of HTLV-1 in Iranian blood donors, HIV-1 positive patients and patients with beta thalassemia.
    J Med Virol. 2018 Apr 16. doi: 10.1002/jmv.25192.
    PubMed     Text format     Abstract available


  24. MOSITES E, Gounder P, Snowball M, Morris J, et al
    Hepatitis A vaccine immune response 22 years after vaccination.
    J Med Virol. 2018 Apr 16. doi: 10.1002/jmv.25197.
    PubMed     Text format     Abstract available


  25. MOSITES E, Gounder P, Snowball M, Morris J, et al
    Hepatitis A vaccine immune response 22 years after vaccination.
    J Med Virol. 2018 Apr 12. doi: 10.1002/jmv.25089.
    PubMed     Text format     Abstract available


    March 2018
  26. SINGH R, Mukherjee A, Singla M, Vajpayee M, et al
    Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children.
    J Med Virol. 2018 Mar 25. doi: 10.1002/jmv.25074.
    PubMed     Text format     Abstract available


  27. CHEN ZW, Liu L, Chen G, Cheung KW, et al
    Surging HIV-1 CRF07_BC epidemic among recently infected men who have sex with men in Fujian, China.
    J Med Virol. 2018 Mar 25. doi: 10.1002/jmv.25072.
    PubMed     Text format     Abstract available


  28. DENG H, Deng X, Liu Y, Xu Y, et al
    Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
    J Med Virol. 2018 Mar 24. doi: 10.1002/jmv.25078.
    PubMed     Text format     Abstract available


  29. GAO L, Wang Y, Li Y, Dong Y, et al
    Genome-wide expression profiling analysis to identify key genes in the anti-HIV mechanism of CD4(+) and CD8(+) T cells.
    J Med Virol. 2018 Mar 6. doi: 10.1002/jmv.25071.
    PubMed     Text format     Abstract available


    February 2018
  30. ZHOU S, Ren L, Xia X, Miao Z, et al
    Hepatitis E virus infection in HIV-infected patients: a large cohort study in Yunnan province, China.
    J Med Virol. 2018 Feb 19. doi: 10.1002/jmv.25060.
    PubMed     Text format     Abstract available


  31. GRECO L, Renteria SCU, Guarneri D, Orlandi A, et al
    HEV and HAV seroprevalence in men that have sex with men (MSM): an update from Milan, Italy.
    J Med Virol. 2018 Feb 15. doi: 10.1002/jmv.25052.
    PubMed     Text format     Abstract available


  32. MANCINELLI S, Pirillo MF, Liotta G, Andreotti M, et al
    ANTIBODY RESPONSE TO HEPATITIS B VACCINE IN HIV-EXPOSED INFANTS IN MALAWI AND CORRELATION WITH HBV INFECTION ACQUISITION.
    J Med Virol. 2018 Feb 10. doi: 10.1002/jmv.25049.
    PubMed     Text format     Abstract available


  33. RAO D, Venkataswamy MM, Vasanthapuram R, Satishchandra P, et al
    Alterations in natural killer and dendritic cell subsets in individuals with HIV-associated neurotuberculosis.
    J Med Virol. 2018 Feb 3. doi: 10.1002/jmv.25042.
    PubMed     Text format     Abstract available


    January 2018
  34. MARIO S, Carmine M, Stefania P, Margherita M, et al
    VIROLOGICAL PATTERNS OF HCV PATIENTS WITH FAILURE TO INTERFERON-FREE REGIMENS.
    J Med Virol. 2018 Jan 9. doi: 10.1002/jmv.25022.
    PubMed     Text format     Abstract available


    December 2017
  35. VERGARA-ORTEGA DN, Sevilla-Reyes EE, Herrera-Ortiz A, Torres-Ibarra L, et al
    REAL TIME PCR TO EVALUATE HSV-2 SHEDDING FROM ANAL AND GENITAL SAMPLES AMONG MEN WHO HAVE SEX WITH MEN, LIVING WITH HIV.
    J Med Virol. 2017 Dec 13. doi: 10.1002/jmv.25003.
    PubMed     Text format     Abstract available


    November 2017
  36. SU S, Fairley CK, Sasadeusz J, He J, et al
    HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    J Med Virol. 2017 Nov 1. doi: 10.1002/jmv.24988.
    PubMed     Text format     Abstract available


    October 2017
  37. CARRASCO I, Arias A, Benitez-Gutierrez L, Lledo G, et al
    Baseline NS5A Resistance Associated Substitutions May Impair DAA Response in Real-World Hepatitis C Patients.
    J Med Virol. 2017 Oct 9. doi: 10.1002/jmv.24971.
    PubMed     Text format     Abstract available


  38. LIU Z, Fang Q, Zuo J, Chen Y, et al
    Global Epidemiology of Human Herpesvirus 8 in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
    J Med Virol. 2017 Oct 3. doi: 10.1002/jmv.24960.
    PubMed     Text format     Abstract available


  39. AMPONSAH-DACOSTA E, Selabe SG, Mphahlele MJ
    Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.
    J Med Virol. 2017 Oct 2. doi: 10.1002/jmv.24956.
    PubMed     Text format     Abstract available


    September 2017
  40. RAHMAN M, Hossain ME, Afrad MH, Hasan R, et al
    Hepatitis C Virus infections among clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol. 2017 Sep 28. doi: 10.1002/jmv.24955.
    PubMed     Text format     Abstract available


  41. UCCIFERRI C, Tamburro M, Falasca K, Sammarco ML, et al
    Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men.
    J Med Virol. 2017 Sep 14. doi: 10.1002/jmv.24943.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: